Regeneron Pharmaceuticals, Inc. (REGN)
NASDAQ · Healthcare
Regeneron Pharmaceuticals, Inc. Shareholder Equity 2008–2025
Regeneron Pharmaceuticals, Inc. annual shareholder equity history from 2009 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Regeneron Pharmaceuticals, Inc. shareholder equity as of December 31, 2025: 31.26B, a 6.48% increase year-over-year.
- Regeneron Pharmaceuticals, Inc. shareholder equity for 2025 were 31.26B, a 6.48% increase from 2024.
- Regeneron Pharmaceuticals, Inc. shareholder equity for 2024 were 29.35B, a 13.02% increase from 2023.
- Regeneron Pharmaceuticals, Inc. shareholder equity for 2023 were 25.97B, a 14.60% increase from 2022.
- Regeneron Pharmaceuticals, Inc. shareholder equity for 2022 were 22.66B.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Regeneron Pharmaceuticals, Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $31,257 |
| 2024 | $29,354 |
| 2023 | $25,973 |
| 2022 | $22,664 |
| 2021 | $18,769 |
| 2020 | $11,025 |
| 2019 | $11,090 |
| 2018 | $8,757 |
| 2017 | $6,144 |
| 2016 | $4,449 |
| 2015 | $3,655 |
| 2014 | $2,550 |
| 2013 | $1,965 |
| 2012 | $1,257 |
| 2011 | $486 |
Regeneron Pharmaceuticals Inc. Shareholder Equity — FAQ
Regeneron Pharmaceuticals Inc. (REGN) shareholder equity over the last 18 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see REGN's shareholder equity history?
The chart and table above show Regeneron Pharmaceuticals Inc.'s shareholder equity by year and by quarter, including the growth rate.